Covid-19: Refuerzo de Pfizer contra Omicron podría autorizarse esta semana By IBL News - 31/08/2022 TwitterFacebookLinkedinWhatsAppEmail Pfizer’s new Covid-19 vaccine booster targeting the omicron BA.4 and BA.5 variants could get FDA authorization as early as this week. Fuente: Youtube